| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 12k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Protagonist Therapeutics, Inc | PTGX | Payment of Exercise | Common Stock | 4.2k | $26.07 | $108.2k | | 05/31/2023 |
| 01/16/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 123.8k | $12.17 | $1.5M | | 01/16/2023 |
| 01/16/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 20.6k | $0.00 | $0 | | 01/16/2023 |
| 04/26/2022 | Protagonist Therapeutics, Inc | PTGX | Exercise | Stock Option (right to buy) | 40k | $7.38 | $295.2k | | 04/26/2022 |
| 02/28/2022 | Protagonist Therapeutics, Inc | PTGX | Payment of Exercise | Common Stock | 649 | $24.28 | $15.8k | | 02/28/2022 |
| 02/15/2022 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/15/2022 |
| 02/15/2022 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 75k | $28.73 | $2.2M | | 02/15/2022 |
| 02/26/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 12k | $0.00 | $0 | | 02/26/2021 |
| 02/26/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 80k | $23.57 | $1.9M | | 02/26/2021 |
| 02/28/2020 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 85k | $7.80 | $663k | | 02/28/2020 |
| 12/03/2019 | Protagonist Therapeutics, Inc | PTGX | Purchase | Common Stock | 30k | $5.13 | $153.9k | | 12/03/2019 |
| 02/28/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 7.5k | $0.00 | $0 | | 02/28/2019 |
| 02/28/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 45k | $8.02 | $360.9k | | 02/28/2019 |
| 01/15/2019 | Protagonist Therapeutics, Inc | PTGX | Exercise | Stock Option (right to buy) | 110k | $7.38 | $811.8k | | 01/15/2019 |